Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Search stocks
Techindia Nirman Ltd

| Standalone Audited Results for Quarter & Year Ended March 31, 2026

Report Source

⬤23rd Apr 26

Summary : Company faces significant governance, financial, and legal challenges, resulting in a qualified audit opinion and cash losses.

Quarterly Report Analysis & Insights

Financial Disclosures

  1. Development Expenses: 1.23 Lakhs (Year ended 31/03/2026)
  2. Employee Benefit Expense: 13.90 Lakhs (Year ended 31/03/2026)
  3. Depreciation & Amortisation Expenses: 4.22 Lakhs (Year ended 31/03/2026)
  4. Other Expenditure: 13.84 Lakhs (Year ended 31/03/2026)
  5. Finance Cost: 29.30 Lakhs (Year ended 31/03/2026)
  6. Revenue from operations: 0.00 Lakhs (Quarter and Year ended 31/03/2026)
  7. Other Operating Income: 0.34 Lakhs (Quarter and Year ended 31/03/2026)
  8. Other Income: 19.69 Lakhs (Quarter ended 31/03/2026)
  9. Net cash from operating activities: -449.73 Lakhs (Year ended March 31, 2026)
  10. Net cash used in investing activities: 0.00 Lakhs (Year ended March 31, 2026)
  11. Net cash from financing activities: 52.75 Lakhs (Year ended March 31, 2026)
  12. Net Decrease in Cash and Cash Equivalents: -396.97 Lakhs (Year ended March 31, 2026)
  13. Cash and cash equivalents at year end: 4.49 Lakhs (as of March 31, 2026)
  14. Impact of sub-judice interest on loan from sister concern is unascertainable
  15. Impact of ongoing CIRP litigation before Supreme Court is unascertainable
  16. Total Assets: 8,123.65 Lakhs (as of March 31, 2026)
  17. Total Liabilities: 8,123.65 Lakhs (as of March 31, 2026)
  18. Equity Share Capital: 1,432.60 Lakhs (as of March 31, 2026)
  19. Other Equity: -403.21 Lakhs (negative, as of March 31, 2026)
  20. Non-Current Assets: 7,518.78 Lakhs (as of March 31, 2026)
  21. Current Assets: 604.86 Lakhs (as of March 31, 2026)
  22. Non-Current Liabilities: 2.67 Lakhs (as of March 31, 2026)
  23. Current Liabilities: 7,091.58 Lakhs (as of March 31, 2026)
  24. Advances for real estate development: 5,320.71 Lakhs (Non-Current Assets)
  25. Current Borrowings: 7,063.30 Lakhs (Current Liabilities)
  26. Borrowings from Agri-Tech India Ltd. (sister concern)
  27. Loans/advances granted to related parties
  28. All related party transactions comply with sections 177 and 188 of the Act
  29. Results are Standalone Audited Results
  30. Company has no subsidiary, associate, or joint venture; consolidation not applicable

Corporate Overview

  1. Two real estate projects in Mumbai
  2. Board composition not in accordance with SEBI (LODR) Regulations due to non-promoter shareholder resistance
  3. Interest payable on loan from sister concern not accounted for (sub judice)
  4. Delays in real estate development due to lack of resources
  5. Delays in setting up R&D laboratory due to lack of resources
  6. Company was under Corporate Insolvency Resolution Process (CIRP) and ongoing litigation in Supreme Court
  7. Uncertainty regarding recoverability of advances for real estate and R&D
  8. Incurred cash losses during the financial year
  9. Borrowings from sister concern (Agri-Tech India Ltd.)
  10. Resources for real estate and R&D projects
  11. Real Estate Development
  12. Addressing challenges and trying to restore normalcy in operations
  13. Committed to regularizing board composition
  14. Real estate development projects (currently delayed)
  15. Setting up R&D laboratory (currently delayed)

Risk Factors

  1. Qualified audit opinion, going concern issues.
  2. Ongoing Supreme Court litigation.
  3. Non-compliance with SEBI board regulations.
  4. Significant cash losses, negative other equity.

Key Drivers

  1. Board reinstated by NCLAT.
  2. Efforts to restore operational normalcy.
  3. Resolution of Supreme Court litigation.
  4. R&D laboratory setup for future growth.

Auditor’s Report

  1. Qualified Opinion
  2. Non-recognition of interest on borrowings from Agri-Tech India Ltd.
  3. Going concern basis due to CIRP and ongoing Supreme Court litigation
  4. Non-compliance with SEBI (LODR) Regulations, including board composition
  5. Uncertainty regarding recoverability of advances for real estate and R&D
  6. Going concern basis due to Corporate Insolvency Resolution Process (CIRP) and ongoing litigation before Supreme Court of India

Board Commentary

  1. Board reinstated by National Company Law Appellate Tribunal (NCLAT)
  2. Appointment of Mrs. Poonam Kagliwal intimated to stock exchanges
  3. Previous statutory auditor resigned, new auditor appointed
  4. No dividend declared, including interim dividend, during the year
  5. Ongoing litigation related to CIRP before Supreme Court
  6. Uncertainty regarding recoverability of significant advances for projects
  7. Non-compliance with SEBI (LODR) Regulations, including board composition
  8. Non-recognition of interest on borrowings from a related party
  9. Company incurred cash losses and has negative other equity
  10. Auditors questioning the going concern basis
  11. Board composition not in accordance with SEBI (LODR) Regulations
  12. Interest payable on loan from sister concern not accounted for, case is sub judice
  13. Corporate Insolvency Resolution Process (CIRP) initiated, set aside by NCLAT, now challenged in Supreme Court
  14. Non-compliance with SEBI (LODR) Regulations
  15. Advances given for Real estate development projects
  16. Advances given for setting up R&D laboratory

Corporate Governance

  1. Board composition not in accordance with SEBI (LODR) Regulations due to non-promoter shareholder resistance
  2. Board composition non-compliance with SEBI regulations
  3. Shareholders raised concerns regarding governance matters
  4. Company was under Corporate Insolvency Resolution Process (CIRP)

Management Discussion & Analysis

Future Strategy

  1. Renegotiate and restore normalcy in real estate operations
  2. Renegotiate and restore normalcy in R&D laboratory setup
  3. Regularize board composition as per SEBI regulations

Operational Focus Areas

  1. Restore normalcy in real estate development
  2. Restore normalcy in R&D laboratory setup
  3. Address board composition non-compliance

Risk Control Measures

  1. Actively trying to renegotiate and restore normalcy in operations
  2. Efforts to regularize board composition

Critical Risks

  1. Ongoing litigation related to CIRP before Supreme Court
  2. Uncertainty regarding recoverability of significant advances for projects
  3. Non-compliance with SEBI (LODR) Regulations, including board composition
  4. Non-recognition of interest on borrowings from a related party
  5. Company incurred cash losses and has negative other equity
  6. Auditors questioning the going concern basis